CANF
USDCan-Fite Biopharma Ltd Sponsored ADR (Israel)
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.110
Kõrge
$1.110
Madal
$1.080
Maht
0.07M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
15.3M
Tööstusharu
Biotehnoloogia
Riik
Israel
Kauplemisstatistika
Keskmine maht
0.28M
Börs
ASE
Valuuta
USD
52 nädala vahemik
Seotud uudised
Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis
Ramat Gan, Israel, May 05, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory
Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite's Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients
Ramat Gan, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and
D. Boral Capital Maintains Buy on Can Fite Biofarma, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains Can Fite Biofarma with a Buy and maintains $10 price target.
Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares
RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory
Seotud aktsiad
ACHL
Achilles Therapeutics plc American Depositary Shares
PHAT
Phathom Pharmaceuticals Inc.
TCRX
TScan Therapeutics Inc.
PGY
Pagaya Technologies Ltd. Ordinary Shares
PYXS
Pyxis Oncology Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.